New Mex. Oncology & Hematology Consultants, Ltd. v. Presbyterian Healthcare Servs. & Presbyterian Network, Inc.

Decision Date14 March 2016
Docket NumberCiv. No. 12–00526 MV/GBW
Citation169 F.Supp.3d 1204
Parties New Mexico Oncology and Hematology Consultants, Ltd., Plaintiff, v. Presbyterian Healthcare Services and Presbyterian Network, Inc., Defendants.
CourtU.S. District Court — District of New Mexico

Brian P. Jakulevicius, George M. Sanders, Thomas Joseph Bacon, Law Office of George M. Sanders, PC, Chicago, IL, J. Douglas Foster, Travis G. Jackson, Geoffrey D. Rieder, Foster, Rieder & Jackson, PC, Albuquerque, NM, for Plaintiff.

Bruce D. Hall, Charles K. Purcell, Rodey, Dickason, Sloan, Akin & Robb PA, Albuquerque, NM, Jeffrey A. Levee, Kate Wallace, Rachel Zernick, Jones Day, Los Angeles, CA, Thomas Demitrack, Jones Day, Cleveland, OH, Toby G. Singer, Douglas E. Litvack, Jones Day, Washington, DC, for Defendants.

MEMORANDUM OPINION AND ORDER

MARTHA VÁZQUEZ

, UNITED STATES DISTRICT JUDGE

THIS MATTER comes before the Court on the Partial Motion of Defendants Presbyterian Healthcare Services and Presbyterian Network, Inc. to Dismiss the Third Amended Complaint with Prejudice and Memorandum in Support, filed April 20, 2015 [Doc. 141]. Defendants seek to dismiss Plaintiff's new claims for monopolization of an alleged “Inpatient Hospital Services” market. The Court, having considered the motion, briefs, relevant law, and being otherwise fully informed, finds that the motion is well taken and will be granted.1

BACKGROUND

Plaintiff New Mexico Oncology and Hematology Consultants, Ltd. (NMOHC) is a professional corporation with its principal place of business located in Albuquerque, New Mexico. [Doc. 123 at 23]. NMOHC is an integrated, comprehensive cancer

treatment facility that offers patients a full range of medical oncology and hematology, radiation oncology, chemotherapy infusion, and radiology and laboratory services. [Id. at 24, 32, 33, 34]. NMOHC offers patients its services at a freestanding cancer

center owned and operated by NMOHC. [Id. at 31]. While NMOHC is based in Albuquerque, it has satellite facilities in underserved areas, including Gallup, Silver City, and Ruidoso. [Id. at 35].

Defendant Presbyterian Healthcare Services (Presbyterian Hospital) is a not-for-profit corporation, with its principle place of business in Albuquerque, New Mexico. [Id. at 36]. Presbyterian Hospital owns, operates, and manages eight acute care hospitals, all of which are located in New Mexico and three of which are located in Albuquerque. [Id. at 37]. Presbyterian Hospital is the largest hospital in New Mexico and offers a full range of services, including comprehensive oncology services. [Id. at 35, 45, 69, 77, 84]. Presbyterian Hospital owns, operates, and manages Presbyterian Medical Group, which employs approximately 700 physicians, including primary care physicians, medical oncologists, and a wide range of other specialists. [Id. at 45].

Presbyterian Hospital also is the ultimate parent company of co-Defendant Presbyterian Network, Inc. [Id. at 39]. Presbyterian Hospital owns and operates Presbyterian Healthcare Services Affiliates, Presbyterian Healthcare Services Affiliates owns Southwest Health Foundation, Southwest Health Foundation owns Defendant Presbyterian Network Inc., and Presbyterian Network Inc. owns and controls Presbyterian Insurance Company, Inc. and Presbyterian Health Plans Inc. [Id. ]. In the interest of brevity, the Court will refer collectively to Presbyterian Network, Inc. and its subsidiaries as “PHP.” [Id. ].

PHP operates, on a for-profit basis, various health maintenance organizations, preferred provider organizations, and other health insurance products. [Id. ]. PHP is the largest health insurer in Albuquerque. [Id. at 43]. Despite the legal separation between Presbyterian Hospital and PHP, Presbyterian Hospital actively controls PHP's actions. [Id. at 44].

Plaintiff filed its Second Amended Complaint (hereinafter “SAC”) [Doc. 24] against Defendants Presbyterian Hospital and PHP, alleging various federal and state antitrust claims, claims under the federal Racketeer Influenced and Corrupt Organizations Act (RICO), and state common law claims. On August 22, 2014, this Court granted in part and denied in part Defendants' Motion to Dismiss the Second Amended Complaint, dismissing Plaintiff's state law claim for injurious falsehood (Count VI) and Plaintiff's claims under RICO (Count VII). Plaintiff filed a Third Amended Complaint (hereinafter “TAC”) on March 19, 2015, [Doc. 123], in which Plaintiff amended its antitrust claims under Counts I, II, IV, and V. Defendants filed the present Partial Motion to Dismiss the Third Amended Complaint on April 20, 2015, asking the Court to dismiss Plaintiff's new antitrust claims. [Doc. 141].

Plaintiff asserts monopolization and attempted monopolization antitrust claims under Section 2 of the Sherman Act, 15 U.S.C. § 2

, and under the New Mexico Antitrust Act (“NMAA”), N.M. Stat. Ann. § 57–1–2. In its SAC, Plaintiff's antitrust claims are premised upon the theory that Defendants used their monopoly in the private health insurance market to employ anticompetitive tactics that harm Plaintiff in the comprehensive oncology market. Plaintiff's monopolization claims under this theory (Counts I, IV) arise out of Defendants' alleged willful maintenance of a monopoly and/or monopsony in the market for private health insurance services through the alleged anticompetitive acts of lowering Plaintiff's reimbursement rates, threatening to terminate Plaintiff's provider contract, and entering into an exclusive arrangement with United HealthCare. [Doc. 24 at 471–76, 483–89]. The Court upheld Plaintiff's antitrust claims related to Defendants' monopoly in the private insurance market. [Doc. 79 at 52–53].

However, Plaintiff's TAC alleges an additional theory for its antitrust claims, which is the subject of the present Partial Motion to Dismiss. Plaintiff now alleges that Defendants used their monopoly in the inpatient hospital services market to harm Plaintiff in the comprehensive oncology market. Plaintiff's monopolization claims under this theory (Counts II, V) arise out of Defendants' alleged willful maintenance of a monopoly in the market for inpatient hospital services through the alleged anticompetitive acts of intimidating physicians who referred patients to NMOCH, actively discouraging and interfering with physician referrals to NMOCH, offering financial benefits for physicians who refused to refer patients to NMOCH, and alterations to Defendants' internal computer system that made it difficult for Defendants to process referrals to NMOCH. [Doc. 123 at 255–63, 267].

Plaintiff also claims attempted monopolization in violation of Section 2

(Count III). In its SAC, Plaintiff's attempted monopolization claim appeared to be based solely on Defendants' alleged attempt to monopolize the comprehensive oncology services market by engaging in the same acts that maintained their monopoly in the private health insurance market. In the TAC, however, Plaintiff's attempted monopolization claim arises out of Defendants' alleged attempt to monopolize the comprehensive oncology services market by engaging in the same acts that maintained both alleged monopolies in the private health insurance market and the inpatient hospital services market.

The Court did not consider claims based on the inpatient hospital services market in Defendants' first Motion to Dismiss because the parties agreed that Plaintiff would amend claims pertaining to Defendants' alleged monopoly of the market for inpatient hospital services. [Doc. 79 at 7, n.3].

STANDARD

Federal Rule of Civil Procedure 12(b)(6)

authorizes a court to dismiss a complaint for “failure to state a claim upon which relief can be granted.” Fed.R.Civ.P. 12(b)(6). “The nature of a Rule 12(b)(6) motion tests the sufficiency of the allegations within the four corners of the complaint after taking those allegations as true.” Mobley v. McCormick, 40 F.3d 337, 340 (10th Cir.1994). The sufficiency of a complaint is a question of law, and when considering a rule 12(b)(6) motion, a court must accept as true all well-pleaded factual allegations in the complaint, view those allegations in the light most favorable to the plaintiff, and draw all reasonable inferences in the plaintiff's favor. See

Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 322, 127 S.Ct. 2499, 168 L.Ed.2d 179 (2007) ; Smith v. U.S., 561 F.3d 1090, 1098 (10th Cir.2009) (citation omitted), cert. denied, 558 U.S. 1148, 130 S.Ct. 1142, 175 L.Ed.2d 973 (2010).

A complaint need not set forth detailed factual allegations, yet a “pleading that offers labels and conclusions or a formulaic recitation of the elements of a cause of action” is insufficient. Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009)

(citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007) ). “Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Id.

To survive a motion to dismiss pursuant to Rule 12(b)(6)

, a plaintiff's complaint must contain sufficient facts that, if assumed to be true, state a claim to relief that is plausible on its face. See

Twombly, 550 U.S. at 570, 127 S.Ct. 1955 ; Mink v. Knox, 613 F.3d 995, 1000 (10th Cir.2010). “A claim has facial plausibility when the pleaded factual content allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft, 556 U.S. at 678, 129 S.Ct. 1937 (citing Twombly, 550 U.S. at 556, 127 S.Ct. 1955 ). “Thus, the mere metaphysical possibility that some plaintiff could prove some set of facts in support of the pleaded claims is insufficient; the complainant must give the court reason to believe that this plaintiff has a reasonable likelihood of mustering factual support for these claims.” Ridge at Red Hawk, LLC v. Schneider, 493 F.3d 1174, 1177 (10th Cir.2007) (emphasis omitted). The Tenth Circuit has explained,

[p]lausibility” in this context...

To continue reading

Request your trial
3 cases
  • In re Dealer Management Systems Antitrust Litigation, Case No. 18-cv-864
    • United States
    • U.S. District Court — Northern District of Illinois
    • January 25, 2019
    ..., 279 P.3d 772, 776 (N.M. Ct. App. 2012) (applying AGC to claim brought under the NMAA); see also New Mexico Oncology v. Presbyterian Healthcare Servs. , 169 F.Supp.3d 1204, 1206 (D.N.M. 2016) (assuming without discussion that AGC applied to claim under NMAA). Accordingly, the Court will ap......
  • Nemickas v. Linn Cnty. Anesthesiologists, P.C.
    • United States
    • Iowa Court of Appeals
    • May 16, 2018
    ...; Konik v. Champlain Valley Physicians Hosp. Med. Ctr. , 733 F.2d 1007, 1009 (2d Cir. 1984) ; New Mexico Oncology v. Presbyterian Healthcare Services , 169 F. Supp. 3d 1204, 1205 (D.N.M. 2016) ; Korshin v. Benedictine Hospital , 34 F. Supp. 2d 133, 134 (N.D.N.Y. 1999) ; Davies v. Genesis Me......
  • N.M. Oncology & Hematology Consultants, Ltd. v. Presbyterian Healthcare Servs.
    • United States
    • U.S. Court of Appeals — Tenth Circuit
    • April 5, 2021
    ...RICO claim and claim for monopolization of the inpatient hospital services market. See N.M. Oncology & Hematology Consultants, Ltd. v. Presbyterian Healthcare Servs., 169 F. Supp. 3d 1204 (D.N.M. 2016) ; N.M. Oncology & Hematology Consultants, Ltd. v. Presbyterian Healthcare Servs., 54 F. S......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT